PubMed:33754144 / 398-577
Annnotations
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-179 | Sentence | denotes | We aimed to evaluate whether mavrilimumab, a monoclonal antibody to the GM-CSF receptor, would improve outcomes in patients with COVID-19 pneumonia and systemic hyperinflammation. |
T4 | 0-179 | Sentence | denotes | We aimed to evaluate whether mavrilimumab, a monoclonal antibody to the GM-CSF receptor, would improve outcomes in patients with COVID-19 pneumonia and systemic hyperinflammation. |
yangbin123xm_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 129-147 | DP | denotes | COVID-19 pneumonia |
T6 | 29-41 | CI | denotes | mavrilimumab |
chenxin_473849_800_3
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 29-41 | CI | denotes | mavrilimumab |
T16 | 129-147 | DP | denotes | COVID-19 pneumonia |